Agenus (AGEN) Insider Trading & Ownership $3.43 +0.22 (+6.73%) As of 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Agenus (NASDAQ:AGEN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$325,000.00Number OfInsiders Selling(Last 12 Months)0 Get AGEN Insider Trade Alerts Want to know when executives and insiders are buying or selling Agenus stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AGEN Insider Buying and Selling by Quarter Agenus Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/15/2024Garo H ArmenInsiderBuy25,000$13.00$325,000.00 (Data available from 1/1/2013 forward) AGEN Insider Trading Activity - Frequently Asked Questions Who is on Agenus's Insider Roster? The list of insiders at Agenus includes Agenus Inc, and Garo H Armen. Learn more on insiders at AGEN. What percentage of Agenus stock is owned by insiders? 4.60% of Agenus stock is owned by insiders. Learn more on AGEN's insider holdings. Which Agenus insiders have been buying company stock? The following insiders have purchased AGEN shares in the last 24 months: Agenus Inc ($568,492.60), and Garo H Armen ($325,000.00). How much insider buying is happening at Agenus? Insiders have purchased a total of 47,628 AGEN shares in the last 24 months for a total of $893,492.60 bought. Agenus Key ExecutivesDr. Garo H. Armen Ph.D. (Age 71)Founder, Executive Chairman & CEO Compensation: $1.34MMs. Christine M. Klaskin (Age 58)VP of Finance, Principal Financial Officer & Principal Accounting Officer Compensation: $407.44kDr. Steven J. O'Day M.D. (Age 63)Ph.D., Chief Medical Officer Compensation: $970.98kCraig WinterChief Information OfficerMr. Zack ArmenHead of Investor RelationsMs. Tracy Mazza ClementeChief People OfficerMr. Alfred DadsonChief Manufacturing OfficerMr. Eric HumesChief Quality OfficerDr. Todd Jude Yancey M.D.Member of Advisory Board & Chief Strategic AdvisorDr. Robin G. Taylor M.B.A.Ph.D., Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies XOMA Insider Trades Verastem Insider Trades Vanda Pharmaceuticals Insider Trades Sangamo Therapeutics Insider Trades Lexicon Pharmaceuticals Insider Trades Achieve Life Sciences Insider Trades Regulus Therapeutics Insider Trades Fortress Biotech Insider Trades SAB Biotherapeutics Insider Trades Bolt Biotherapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles META Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying Signals This page (NASDAQ:AGEN) was last updated on 2/12/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Policies Are Going to Light a Fire Under GoldHow You Can Profit from Trump's Bold Moves in 2025 Donald Trump’s bold policies are creating unprecedented ...Golden Portfolio | SponsoredMust-See: Trump’s Shocking AI AnnouncementIf you have any investments in AI stocks or are interested in AI… Please take a moment to review the detail...Brownstone Research | SponsoredThe Secret Winner in Trump’s AI RevolutionTrump just announced a $500 billion plan to revolutionize artificial intelligence. He's calling it The Star...Behind the Markets | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredFrom bankrupt to delivering 610,000% returnsWalk the empty streets of this barren town and you would have no idea that behind the sand-scarred blight is o...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agenus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agenus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.